Skip to main content
Top
Published in: Rheumatology International 2/2003

01-03-2003 | Original Article

Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium

Authors: Insa Hilbers, Torsten Hansen, Peter K. Petrow, Andreas Gaumann, Rolf Bräuer, Günther Salzmann, Renate E. Gay, Hartwig Kosmehl, James C. Kirkpatrick, Steffen Gay, Jörg Kriegsmann

Published in: Rheumatology International | Issue 2/2003

Login to get access
Metadata
Title
Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium
Authors
Insa Hilbers
Torsten Hansen
Peter K. Petrow
Andreas Gaumann
Rolf Bräuer
Günther Salzmann
Renate E. Gay
Hartwig Kosmehl
James C. Kirkpatrick
Steffen Gay
Jörg Kriegsmann
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-002-0255-2

Other articles of this Issue 2/2003

Rheumatology International 2/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine